New approach for teens with severe liver failure
Part of Digestive system clinical trials.
This study is looking at a new way to treat severe liver disease in young people when a regular liver transplant isn't possible. It might help if your liver is failing and you can't get a transplant from a donor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 7 and 18 years old.
- You have severe, end-stage liver disease.
- A standard liver transplant isn't possible because you don't have enough healthy donor liver available.
- You are healthy enough to have surgery.
- Your guardians (and you, if you're over 14) agree to take part and sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study combines two surgeries—first removing part of the tumor, then a liver transplant—for patients with advanced liver cancer or liver failure. It aims to offer a chance for cure when standard treatments are not possible.
This Phase 2 study tests whether transplanting donor liver cells near lymph nodes can improve outcomes in people with advanced cirrhosis from certain liver conditions. It may help your liver function by adding healthy liver cells, but eligibility is tightly based on your current liver status and other health factors.
This trial tests a treatment called SALT for people with liver cirrhosis caused by hepatitis B. It aims to see if it can improve liver function and reduce complications.
This study tests whether giving a liver transplant to people with cirrhosis and small liver tumors from hepatitis B can help them live longer. It compares outcomes for patients who meet specific tumor size criteria.
This trial is testing a new approach for people whose colorectal cancer has spread to the liver and cannot be removed by surgery. The treatment involves a liver transplant, so it is for patients whose tumors are stable or improving after chemotherapy and have not spread beyond the liver (or have only a few removable lung spots). It aims to improve outcomes for patients with limited options.
This study looks at when liver transplant is offered and what outcomes happen in people with cirrhosis who have severe “acute-on-chronic” worsening. It may help doctors decide which patients benefit most from transplant and improve care after listing or not listing.
Hear when a new End Stage Liver DIsease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.